Zai Lab (ZLAB) EBT (2018 - 2026)

Zai Lab has reported EBT for 9 years, with the latest figure at -$49.6 million in Q1 2026.

• Quarterly EBT fell 2.35% year-over-year to -$49.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$179.6 million (up 28.75% YoY) and the FY2025 annual result came in at -$178.5 million, up 30.59% from the prior year.
• EBT rose to -$49.6 million in Q1 2026 per ZLAB's latest filing, from -$53.3 million in the prior quarter.
• Over five years, EBT peaked at -$36.0 million in Q3 2025 and troughed at -$161.2 million in Q3 2022.
• A 5-year average of -$74.3 million and a median of -$61.8 million in 2022 frame the typical range for EBT.
• The widest YoY moves for EBT: up 70.77% in 2022, down 67.78% in 2022.
• Over 5 years, EBT stood at -$61.8 million in 2022, then plunged by 54.49% to -$95.4 million in 2023, then increased by 14.4% to -$81.7 million in 2024, then soared by 34.7% to -$53.3 million in 2025, then advanced by 7.05% to -$49.6 million in 2026.
• According to Business Quant data, EBT over the past three periods registered -$49.6 million, -$53.3 million, and -$36.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.